Loading…
Loading…
The9 NASDAQ: NCTY reported second-quarter net income of $32 million, up more than 39% from the prior quarter, as the company advanced its repositioning around The9bit, an AI-powered game creation platform supported by a token-based ecosystem.
Increase driven by the fair-value recognition of 9BIT tokens received under the Company's cooperation agreement with the 9BIT Foundation as the9bit continued to expand AI capabilities, community engagement and commercial partnerships SHANGHAI, Aug. 24, 2026 /PRNewswire/ -- The9 Limited (Nasdaq: NCTY) ("The9" or the "Company"), a global, diversified high-tech company, today reported its unaudited financial results for the three months ended June 30, 2026. Second Quarter 2026 Highlights Strong sequential growth: Net income for the quarter was US$32 million, an increase of more than 39% from the previous quarter.
The9's Investee Nanyang Biologics (NYB) Advancing toward Nasdaq Listing after RFAI Cleared Vote at Shareholders Extraordinary General Meeting
Milestone Marks Further Progress in The9's Strategic Investment in AI-Driven Drug Discovery; The9 Expects to Hold Approximately 15% to 16% of the Combined, Nasdaq-Listed Company SHANGHAI, Aug. 21, 2026 /PRNewswire/ -- The9 Limited (Nasdaq: NCTY) ("The9" or the "Company"), a global, diversified high-tech company, today announced that Nanyang Biologics Pte. Ltd. ("NYB"), a Singapore-based, AI-driven drug discovery company in which The9 holds a strategic equity stake, has taken a significant step toward its planned Nasdaq listing.
SHANGHAI, Aug. 17, 2026 /PRNewswire/ -- The9 Limited (Nasdaq: NCTY) ("The9" or the "Company"), a global, diversified high-tech company, today announced that it will report its unaudited consolidated results for the second quarter ended June 30, 2026, before the U.S. market opens on Monday, August 24, 2026. The Company will host a conference call on Monday, August 24, 2026 at 8:30 PM Hong Kong Time (8:30 AM U.S. Eastern Time) to discuss the results.
NYB Obtained Notice of Effectiveness from SEC for Its Form F-4 Registration Statement The9 expects to own 15% to 16% of the combined company following NYB listing HONG KONG, Aug. 11, 2026 /PRNewswire/ -- The9 Limited (Nasdaq: NCTY) ("The9" or the "Company"), a global diversified high-tech company, today announced that its Singapore investee Nanyang Biologics Pte. Ltd. ("NYB") obtained the notice of effectiveness from the U.S. Securities and Exchange Commission for its Form F-4 registration statement filed in connection with the previously announced business combination, a key milestone toward NYB's planned listing on Nasdaq under the reserved ticker symbol "NYB.
the9bit Signs 41 Brand Partners Across Indonesia, Malaysia, and Vietnam, with 127 More in the Pipeline SHANGHAI, Aug. 6, 2026 /PRNewswire/ -- The9 Limited (Nasdaq: NCTY) ("The9" or the "Company"), a global diversified high-tech company, today announced continued progress in the Southeast Asia offline-to-online ("O2O") initiative of the9bit, its AI-powered digital asset ecosystem. The initiative has built a growing network of brand partnerships across Indonesia, Malaysia, and Vietnam as part of a strategy of integrating digital entertainment experiences with physical retail environments.
The9 Posts Record Quarterly Profit; Expects Sequential Growth Through 2026 PR Newswire SHANGHAI, July 27, 2026